A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

NCT01154140 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

343

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Squamous Lung Cancer

Interventions

DRUG: treatment
DRUG: treatment

Sponsor

Pfizer